Results 291 to 300 of about 21,836 (300)

Recent Insights into the Paradoxical Effect of Echinocandins

Journal of Fungi (Basel, Switzerland), 2018
Johannes Wagener
exaly  

Biosynthesis of pneumocandin lipopeptides and perspectives for its production and related echinocandins

Applied Microbiology and Biotechnology, 2018
Yan Li, N. Lan, Lijian Xu, Qun Yue
semanticscholar   +1 more source

Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences

Antimicrobial Agents and Chemotherapy, 2007
Russell E. Lewis
exaly  

Echinocandins

Infectious Diseases in Clinical Practice, 2005
openaire   +2 more sources

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

Drug Resistance Updates, 2011
exaly  

Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method

Antimicrobial Agents and Chemotherapy, 2017
Eric Dannaoui, Michaela Lackner, Maurizio Sanguinetti   +2 more
exaly  

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

Antimicrobial Agents and Chemotherapy, 2002
exaly  

Echinocandin Antifungal Drugs

2005
John R. Graybill, Gregory M. Anstead
openaire   +2 more sources

Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties

Antimicrobial Agents and Chemotherapy, 2017
exaly  

Cryptococcus neoformans Resistance to Echinocandins: (1,3)β-Glucan Synthase Activity Is Sensitive to Echinocandins

Antimicrobial Agents and Chemotherapy, 2005
exaly